Company intelligence
Allogene Therapeutics
About Allogene Therapeutics
Allogene Therapeutics, with headquarters in South San Francisco, is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T) products for cancer and autoimmune disease. For additional information on our guidelines, please visit www.allogene.com/news-center#community-guidelines Please be aware that the FBI recently issued a warning about an increased number of fake job postings for remote work employment that target applicants' personally identifiable information. All approved Allogene Therapeutics positions are accessible via the Allogene Careers page at www.allogene.com/careers.
Verified activity
Signals from Allogene Therapeutics
2 published signals
Presence & Recognition
Allogene Therapeutics will be attending the Citi Biopharma Back to School Conference in New York tomorrow to share updates on its pipeline and corporate strategy.
Reported by Allogene Therapeutics
Presence & Recognition
Allogene Therapeutics will participate in upcoming fall investor conferences to share updates on its investigational pipeline and corporate strategy.
Reported by Allogene Therapeutics